We have adapted a murine model of heterotypic rotavirus infection for the purpose of evaluating the intestinal antibody response to an infection that mimics human vaccination. Neonatal mice were infected with the rhesus rotavirus (RRV). The enzyme-linked immunospot assay was used in order to avoid common artifacts in the quantitation of intestinal immune responses inherent in measurements of luminal or serum immunoglobulins and to obtain easily quantifiable data in a flexible and convenient format. Functionally active lymphocytes were harvested from the spleen, small intestinal lamina propria, Peyer's patches, and mesenteric lymph nodes and processed into single-cell suspensions. Antibody-secreting cells (ASC) were quantitated from 5 to 50 days after infection for total, RRV-specific, baculovirus-expressed VP4-specific, and single-shell RRV-specific ASC secreting either immunoglobulin G (IgG), IgM, or IgA. The response to VP4 constituted less than 1.5% of the total virus-specific response, which was located almost exclusively in the gut and was 90% IgA. Intestinal ASC were directed overwhelmingly toward proteins incorporated in the single-shell particle, predominantly VP2 and VP6. We conclude that the antibody response to VP4, thought to be the site of the important neutralization sites conserved among several rotavirus serotypes, is an extremely small portion of the overall antibody response in the intestinal tract.
Rotavirus has been clearly shown to be the major cause of severe gastroenteritis and a leading cause of death in infants and young children around the world. Efforts at vaccine development have been proceeding rapidly, but difficulty has emerged in obtaining sufficiently broad protection against disease caused by the several human rotavirus serotypes. One of the barriers to a highly successful vaccine strategy has been the lack of a basic understanding of the factors that determine many aspects of the immune response to vaccination.
The principal failure of vaccine candidates in field trials may have been due to the limited immune response elicited to regions of the rotavirus that mediate heterotypic neutralization. This characteristic, as presently understood, is mediated by antibodies directed at limited regions of the two outer shell proteins: the VP5 segment of VP4, and specific regions of VP7 (34, 37, 62, 63) . Antibodies directed at numerous other epitopes on these two proteins mediate strain-or type-specific neutralization. Considerable confusion has arisen concerning the relative antigenicities of these two proteins and among the various homotypic and heterotypic neutralization regions within them. The mechanisms by which particular regions of these proteins are targeted by the antibody response are obviously among those of critical importance in determining the effectiveness of vaccination (22) .
We have developed a model of murine intestinal antibody response to heterologous infection with rhesus rotavirus, a candidate vaccine strain used extensively in field trials (11, 18, 19, 53, 54, 67) . This model, which uses the enzymelinked immunospot (ELISPOT) assay to enumerate specific antibody-secreting cells (ASC), has been characterized previously in terms of the time course of the response, tissue localization, and isotype distributions (40a) .
This model of immune response has several advantages over other approaches that measure titers of antibodies in serum or intestinal contents or in vitro culture systems, as the results are not confounded by antibody degradation, mucus entrapment, tissue culture artifacts, or other wellknown deficiencies of these measurements.
In this article, we report the VP4-specific response of intestinal lymphocytes following a single enteral rhesus rotavirus (RRV) infection. This approach has been made possible by the expression of antigenically authentic VP4 from baculovirus expression systems, which provides sufficient VP4 to serve as an antigenic target in the ELISPOT assay (34, 36, 37) . Previous attempts to study proteinspecific responses have been limited by the lack of adequate quantities of isolated rotavirus proteins of antigenic similarity to assembled capsid proteins. As an alternative approach, an epitope-specific blocking immunoassay with monoclonal antibodies has been used to indirectly assess the antibody response to particular rotavirus proteins and specific epitopes contained by them (22, 56) . The production of antigenically conserved rotavirus proteins in the baculovirus expression system, however, promises to permit comprehensive determinations of the protein specificity of antirotavirus antibody responses in a variety of immunoassays. The ability of this system to detect intestinal responses to VP4 with excellent sensitivity and specificity will allow the development of a greater understanding of the mechanisms that determine the immunogenicity of a particular protein component of a complex replicating intestinal antigen and may lead to improved vaccine strategy. (66) . The cell suspension was subjected to a discontinuous Percoll gradient centrifugation to isolate viable mononuclear cells, which were enumerated by trypan blue exclusion. Spleen, Peyer's patches, and mesenteric lymph node tissues were minced and forced through steel mesh; clumps were allowed to settle, and the supernatant was decanted. Splenic erythrocytes were lysed with 0.83% ammonium chloride. Mononuclear cells from these tissues could be reliably counted without Percoll gradient centrifugation.
Expression of VP4. VP4 was expressed by a recombinant baculovirus vector in Sf9 cells as previously described (37) . The hemagglutination titer of the sonicated preparation was 1:2,000. This preparation was diluted 1:50 in Tris-salinecalcium chloride (TNC) buffer before use. The cell extracts were sonicated for 20 s and used as the capture antigen in the ELISPOT assay.
ELISPOT. We devised a modification of the ELISPOT technique to measure the number of ASC present in spleen, lamina propria, Peyer's patches, and mesenteric lymph nodes (14) . We individually measured immunoglobulin G (IgG)-, IgM-, and IgA-secreting cells in each of the tissues. We measured all cells secreting antibody specifically directed at double-shelled RRV, single-shelled RRV, or baculovirus-expressed VP4. Immobilon PVDF (Millipore), a white hydrophobic polyvinylidene difluoride membrane, was used as the protein-binding matrix. The membrane was mounted in a 16-or 28-lane Miniblotter (Immunetics, Cambridge, Mass.).
The membrane was coated with the desired capture antigens, which included rotavirus elements listed above diluted in TNC or rabbit anti-mouse IgG, goat anti-mouse IgM, or goat anti-mouse IgA diluted in phosphate-buffered saline (PBS). The optimal concentrations for the antigen capture substances had been determined previously in titration experiments with appropriate hybridoma cells as positive and negative controls. Rotavirus used as capture antigen was purified on cesium chloride density gradients as previously described (58) . Single-shelled particles, devoid of the VP4 and VP7 proteins constituting the outer shell, were produced b Ratio of spots generated by identical numbers of hybridoma cells in VP4 and RRV capture lanes. The VP4 from the recombinant baculovirus expression system was present in adequate amount to permit antibody 7A12 to give approximately as many spots as with intact rotavirus particles, and the specificity was very high, as there was no cross-reactivity with VP6-or VP7-specific hybridomas.
c Ratio of spots generated against EDTA-treated single-shelled (SS) RRV, which was then rebanded in an isopycnic gradient, compared with the spots generated against intact, gradient-purified double-shelled (DS) RRV. Singlecapsid virus is predominantly VP6 (65%) and VP2 (9%o) (17) .
from double-shelled particles by EDTA treatment as described previously (16) .
This template was then incubated at 37°C for 2 h on a rocking platform. Lanes were washed with PBS to remove excess capture antigen, and then the membrane was blocked with PBS containing 5% fetal bovine serum and incubated for 1 h. Cell viability was assessed by trypan blue exclusion, and the appropriate dilutions in RPMI 1640 medium containing 2% fetal bovine serum were made so that a countable number of spots resulted in each lane after 60 
RESULTS
ELISPOT. The specificity of the ELISPOT assay was established by the use of rotavirus-specific hybridomas. Integrity of rotavirus antigen was monitored by hybridomas 4F8 (VP7 specific), 7A12 (VP4 specific), and 255/60 (VP6 specific) (34, 37, 55 shell-and outer shell-specific hybridomas, indicating that intact viral particles were functioning efficiently as antigenic targets for secreted antibodies. The antigenic integrity of the expressed VP4 was confirmed by the pattern of reactivity of hybridoma 7A12, which produced as many spots when VP4 was used as a capture antigen as when whole virus was used, while the VP4 preparation did not capture antibodies secreted by the other hybridomas. Verification that the assay measured secreted antibodies and not membrane-bound fragments was provided by experiments in which hybridoma cells were incubated in cycloheximide prior to the ELISPOT assay. In these experiments, the number of ASC detected declined 70 to 90% (data not shown), a typical result reported by others for this technique (13) .
Time course of ASC and RRV-specific ASC appearance. Cells harvested from spleen, Peyer's patches, mesenteric lymph nodes, and small intestine lamina propria were harvested from 3 to 60 days after infection with RRV. These cells were independently assayed for secretion of IgG, IgM, and IgA antibodies as well as those antibodies specific for gradient-purified double-shelled rotavirus particles, baculovirus-expressed VP4, and, in some experiments, those specific for single-shelled RRV.
The overall response to the virus was concentrated in IgG and IgA in the small intestine lamina propria, as Table 2 illustrates and is discussed below. For this reason, data illustrating the time course of the response will be presented for this tissue and these antibodies only. Figure 1 illustrates the time course of the development of total IgG and IgA ASC in the lamina propria of the small intestine of animals that were infected with RRV at 9 to 12 days of age. In addition, IgG-and IgA-secreting cells specific for RRV or VP4 are also represented. The marked rise in IgA ASC between days 15 development of a plateau at this time is relatively early, however, and the rate of development of the total pool of IgA ASC may have been enhanced by the RRV infection, although that conclusion cannot be drawn from these data alone.
The RRV-specific antibody responses of the small intestine lamina propria lymphocytes were followed through 50 days postinfection. The very first small intestine ASC responding to rotavirus were noted on day 3 to 4 postinfection but rose rapidly to a plateau which was established between days 20 and 30 postinfection. It is very clear that the response is almost entirely IgA. While it appears from the data presented that the IgA response to RRV trends downward between 40 and 50 days after infection, the limited data that we have obtained for animals at 90 and 180 days postinfection suggest that this decline is not significant at these times. At all time points from day 20 onward, there was very little difference in magnitudes of responses or the relative contributions of IgG, IgM, or IgA antibodies. For this reason, data from these time points were pooled for further analyses.
The time course of the small intestine antibody response to the RRV outer shell hemagglutinin VP4 parallels that of the response to whole virus. The overall level of the VP4-specific response was less than 2% of the response to whole virus at all time points (note logarithmic axis of Fig. 1 ) except day 5 postinfection, but this was not statistically significant (Fig. 1) .
VP4 specific ASC for four tissues during days 20 to 60 postinfection. The frequency of ASC in the small intestine far exceeded that in the other tissues studied ( Table 2 ). The distribution of the rotavirus-specific ASC mirrors the distribution of all ASC. Roughly half of all small intestinal ASC were virus specific. This finding is consistent with other data we have reported (40a). The small intestinal lamina propria contained the greatest frequency of VP4-specific ASC of the tissues studied. The other tissues had far fewer relative and absolute numbers of VP4-specific ASC, but in the case of spleen and mesenteric lymph nodes, there were significantly more VP4-specific ASC in the RRV-specific population than one would expect from an extrapolation of the lamina propria frequencies. However, the small number of specific ASC in these tissues makes analysis of ratios difficult. In the case of the spleen, the small numbers of background ASC make this ratio meaningless. No such background was observed in the mesenteric nodes; the number of specific ASC was very consistent, and the difference in the ratio compared with that in the lamina propria was very large. The lamina propria ratio was 0.012 + 0.004, and that of the mesenteric lymph nodes was 0.356 + 0.13. Analysis of variance for the tissues showed highly significant differences [F(3,52) = 15.392, P = 0.0001], and the Scheffe F test for multiple comparisons showed significance at 95% for the difference between the ratio in the lamina propria or Peyer's patches and that in the mesenteric lymph nodes. This finding suggests that variations in viral antigen specificity exist in ASC within different tissues.
Single-shelled and double-shelled RRV. Isopycnic gradientpurified RRV was treated with EDTA to remove the outer capsid containing VP4 and VP7. As shown in Table 1 , this single capsid (or single-shelled) preparation demonstrated the desired antigenic characteristics: it was not recognized by hybridomas secreting monoclonal antibodies specific for VP7 or VP4, but it was efficiently recognized by the hybridoma specific for VP6 (255/60). Including all tissues (small intestinal lamina propria, spleen, Peyer's patch, and mesenteric lymph node) and antibody types (IgG, IgM, and IgA) from experiments in which both single-shelled and doubleshelled RRV were evaluated for the same pool of cells, single-shelled RRV identified 96.4% + 0.128% (n = 119) of the ASC identified by intact double-shelled RRV (data not shown). Single-shell-specific ASC results were compared with double-shell-specific ASC results, and the results were studied in an analysis of variance with tissue of origin and antibody type as the variables. No significant differences (P < 0.05) or trends (P < 0.10) were evident. If all ratios in which either the single-shell-specific ASC or the doubleshell-specific ASC result was <100 were discarded (to eliminate the potentially disruptive effects of small spot numbers on the ratios), the results were the same: 97.3% as many single-shell-specific ASC were identified as double-shellspecific ASC overall, and the analysis of variance identified no differences within groups defined by tissue of origin or antibody type. The overall responses to single-shelled and double-shelled RRV were not significantly different (Table   3) . Early (31) . Many aspects of the host response to viral infection of the intestinal tract are as yet unknown, but this information is obviously of interest in the development of vaccine strategies and can assist in the improvement of our understanding of basic mechanisms of intestinal immune defenses. The present study addresses particularly the specificity of the intestinal antibody response for the viral surface protein VP4.
The selection of a homologous or heterologous animal model may be an important determinant of several aspects of the intestinal antibody response to rotavirus infection or vaccination. Work in murine models has clearly demonstrated that heterologous infection (i.e., a laboratory infection of mice with a virus that naturally infects another species) is a far less efficient process than is homologous infection with a murine rotavirus. The "natural" homologous infection produces disease with a very small input of infectious virus, far greater viral replication occurs, and the infection is more readily spread to others (23, 27, 52, 59, 73) . Limited replication of RRV does occur in the mouse intestine (52), however, and a very large immune response is elicited. It is as yet unclear whether the higher degree of viral replication that occurs during a homologous infection is a significant determinant of the antibody response. Presently available evidence does not clearly show the importance of this factor in the murine model, but investigations are not complete. Dharakul et al. provided direct characterization of the intestinal response to homologous murine infection and found a time course and magnitude of response which were expressed in terms of antibody-bearing cells identified in immunohistochemical studies of intestinal tissue sections (15) . These studies documented that 50% of immunoglobulin-bearing cells were virus specific, and the peak response was not seen until beyond 30 days postinfection. These findings bear remarkable similarity to our data from a heterologous model (Tables 2 and 3 ). The protein specificity of antibodies elicited in response to homologous or heterologous infection may also be similar. Taniguchi et al. have recently reported human studies comparing the response to natural infection with that to vaccination with simian RRV with the epitope-specific blocking immunoassay. The authors' conclusion was that the immunity patterns found after natural infection and vaccination "seem to be essentially the same" (64) . The heterologous model studied here (murine infection by a simian serotype 3 virus) has been widely used to evaluate serological markers and cytotoxic T-cell responses to rotavirus infection (42) (43) (44) (45) (46) 48) and is a logical choice to use to study the response to a process similar to human vaccination with naturally attenuated animal viruses.
Rotaviruses contain two outer shell proteins, VP4 and VP7, that elicit neutralizing antibodies, and which surround an inner protein capsid constructed mostly of VP6 and VP2 (17, 38) . The specificity of this rotavirus ELISPOT assay is elegantly controlled by the use of specific monoclonal antibodies directed at the two outer capsid proteins and also VP6. Antibody 7A12 was used as a VP4-specific control, and this antibody demonstrated VP4-specific activity at a rate of 88% of RRV-specific activity. Antibody 4F8, directed at VP7 (a capture antigen not present in the expressed VP4 preparation but easily detected on whole RRV), was very efficient at detecting virus but virtually never resulted in falsepositive spots in VP4 capture zones. Antibody 255/60, directed at the inner-shell protein VP6, also detected whole RRV but never VP4. Therefore, as used to detect ASC in this assay, our capture antigens for RRV and VP4 provided comparable sensitivity and excellent specificity. We performed large numbers of experiments with nonimmunized and mock-infected mice and proved that the virus-specific responses in these animals were negligible, with the exception of spleen cells secreting IgG or IgM (but not IgA), which consistently produced 10 to 50 ASC/106 mononuclear cells to capture zones with double-or single-shelled RRV or expressed VP4. Approximately one-third of this response was directed at lanes with no capture antigen that were blocked with fetal calf serum. These spots were present at the same rate regardless of the age of the mice and occurred in mice with no serological antirotavirus activity. We assume that these cells represent activity unrelated to virus infection.
Passive protection studies in mice and several other species have confirmed the ability of neutralizing antibodies directed at either outer capsid protein to protect against disease (2, 5, 17, 38, 39, (46) (47) (48) (24, 28, 29) . While the contributions of the gene 4 and gene 9 products (VP4 and VP7, respectively) mediating viral neutralization were further clarified in genetic studies with simian and bovine rotavirus reassortants, data concerning the relative immunogenicity of the two proteins during infection or vaccination and the roles of antibodies to these proteins in active disease protection remain confusing (22, 45) . It has long been recognized that regardless of the route of antigen presentation, the major inner capsid protein VP6 (which does not mediate neutralization or protection) elicits the greatest antibody response of all the rotavirus proteins (17) .
VP7 was initially thought to be immunodominant among the neutralizing antibodies from studies of hyperimmune sera obtained from rabbits that had been hyperimmunized with simian rotaviruses (8, 12, 32) . Several subsequent studies with a variety of techniques identified important and sometimes dominant roles for neutralizing antibodies to VP4 elicited by parenteral inoculation or intestinal infection in serum and intestinal secretions of mice and piglets (25, 26, 45, 47) . There was some evidence that the oral route of antigen presentation in mice may influence the specificity of the antibody response toward VP4 (57) . Children were found to mount an antibody response to VP4 after oral inoculation with two candidate vaccine strains or in some cases of natural infections, but in other studies children seemed to have a lesser heterotypic response than adults (6, 22, 56, 61) . Also, adults orally challenged with a virulent human rotavirus had a dominant neutralizing antibody response directed at VP4. Other studies, however, have continued to demon-strate the dominance of VP7 as a neutralization antigen after oral presentation of homotypic and heterotypic challenges (69) .
The data presented in this article are an attempt to enhance the quantitative information available on the protein specificity of the antibody response in a murine model of heterotypic infection. The ability to obtain this information derives from the adaptation of the ELISPOT assay as a superior tool for quantification of this response and the availability of adequate quantities of baculovirus-expressed, antigenically conserved VP4. Therefore, the relationship of the expressed VP4 to that present on intact rotavirus particles is obviously important in the interpretation of these results. The similarity of these two forms of VP4 has been well established in prior publications (36, 37, 68) . Expressed VP4 has been shown to share the functional characteristics of native VP4 as a hemagglutinin. Immunization of mice with expressed VP4 resulted in the production of high-titer rotavirus antiserum, which included predicted serotypic crossreactivities based on previously characterized regions located on the VP5 fragment of VP4. Furthermore, a highly characterized library of 11 monoclonal antibodies directed at six different antigenic domains of VP4 (including the antibody used in this study, 7A12) were all demonstrated to bind expressed VP4 nearly as well as or better than whole virus in solid-phase immunoassays (35) . There is no evidence to date to indicate any antigenic difference between the expressed VP4 and the VP4 in viral capsids. The antigenic similarity of these two forms of VP4 has led others to attempt to define serologic classifications of rotaviruses based on patterns of antibody reactivity to baculovirus-expressed VP4 (21) . Therefore, the data we present, determined from the number of cells responding to expressed VP4 (Table 2) , very likely represent a reasonable approximation of the sum of the antibodies directed at native VP4.
The data presented in this article confirm prior studies indicating that VP4 stimulates the production of specific antibodies following heterologous rotavirus infection, and our studies further localize the response to the intestinal mucosa. However, while the overall response to whole virus demonstrated the remarkable potency of rotavirus as an intestinal antigen, VP4-specific ASC constituted less than 2% of the virus-specific cells. VP4 constitutes about 1.5% of total virion mass (17, 33) . VP6 and VP2 together constitute 96% of the single capsid particle and were probably the target for a substantial percentage of the ASC in this study. The responses, therefore, seem to be roughly consistent with the relative amounts of each protein present in the virion. It remains to be seen whether the amount of viral replication or the size of the inoculum influences the VP4 specificity of the antibody response.
While no data are presented in this article regarding the antibody response to the other important outer capsidneutralizing protein VP7, this is obviously a subject of interest. To date, it has not been possible to obtain an expressed VP7 that meets the stringent criteria for antigenic similarity to native VP7 that has been documented for the expressed VP4 used in this study, so The intestinal antibody response to rotavirus reported herein can be compared with the responses to other intestinal antigens that have been described previously. The primary location of the antibody response in the small intestinal lamina propria and the dominance of IgA are consistent with the response to cholera toxin (20, 60) . The overall magnitude of the response to rotavirus is very strong in comparison with that to other antigens that have been studied with similar techniques, which in many cases respond at a level comparable to that to VP4 alone (10, 60, 66, 70) . This fact may explain the measurable functional effects of anti-VP4 antibodies in some studies, which may be detectable despite the relatively small fraction of the total antibody response to virus that these antibodies represent. We have not studied the anti-VP4 antibodies in neutralization assays, and we wish to emphasize that even though they represent a minor element of the overall antibody response, these relatively small numbers of VP4-specific antibodies may still represent a significant contribution to the overall neutralizing capacity of this response in light of the fact that antibodies directed to antigens on the single-capsid particles are not neutralizing.
Rotavirus is known to bind to and perhaps replicate within M cells and be transmitted directly to Peyer's patch cells, one possible pathway of presentation to the immune system that is used by many other nonreplicating or mucosally noninvasive antigens (e.g., horseradish peroxidase, cholera toxin, and reovirus) (7, 10, 49, 50, 51, 72 ). An alternative mechanism for antigen presentation that seems plausible for rotavirus involves infection of villous tip epithelium and an encounter with antigen-presenting cells in the intraepithelial compartment or in the lamina propria, a mechanism which would be suitable for a pathogen such as rotavirus that invades the intestinal epithelium. Also, a role for the intestinal epithelial cell in antigen presentation, now known to have such capability, may also exist (3, 9, 40, 41, 71 
